Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Martin Bauer North America is a premier provider of botanical ingredients and herbal extracts for the healthcare, dietary supplement, and food and beverage industries. As the North American division of the global Martin Bauer Group, the company leverages a vast international sourcing network to provide high-quality plant-based raw materials. Their product portfolio includes standardized extracts, botanical powders, and customized tea blends, all produced under strict quality control standards. The company offers extensive manufacturing services such as milling, blending, and steam sterilization across its multiple U.S.-based facilities. Following the acquisition of BI Ingredients, Martin Bauer North America has significantly expanded its processing capabilities and ingredient offerings. They focus on sustainability and transparency, providing farm-to-fork traceability for many of their botanical products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Martin Bauer North America.